Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 575.8043 ↑ 0.75%
[as on 11 August, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 11 August, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option 13.08% 0.75% 0.69% 2.4% 6.92% 13.57% 18.14% 13.3% 22.4% 15.28%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 24.78% 0.63% 1.75% 5.34% 13.75% 23.58% 23.75% 17.84% 25.12% 13.98%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -1.39% -0.33% -0.41% 2.01% 5.47% 4.41% 10.63% 9.72% 13.16% 11.53%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH 2.95% -0.57% -0.66% -0.32% 0.74% 6.43% 15.42% 17.7% 19.41% 14.96%
SBI PSU Fund - REGULAR PLAN -Growth 1.32% -0.01% 0.1% -0.31% -1.78% 10.23% 23.24% 23.5% 20.01% 13.9%
SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH -3.88% -0.45% -0.53% 2.38% 2.43% -3.32% 7.28% 13.5% 15.67% 13.17%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -10.27% 7.14% 3.79% 2.14% 67.04% 22.66% -10% 40.12% 34.25% -3.81%

Discrete returns (monthly)

MonthOct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026
Returns 2.16% 0.82% -1.31% -4.73% 5.23% -4.93% 5.96% 2.29% 5.39% 2.64%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.71% 5.48%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.45% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.55%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology8.45%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.41%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.96%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.86%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.36%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.15%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.15%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.87%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.81%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.77%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.64%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.43%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.17%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.94%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.90%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.72%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.67%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.51%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.16%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.12%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.11%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.94%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.93%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.89%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.88%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.62%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.38%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 31 March, 2026

NAV history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 August, 2026575.8043 0.75%
10 August, 2026571.5271 0.09%
7 August, 2026571.0216 -0.02%
6 August, 2026571.1143 0.08%
5 August, 2026570.6777 -0.21%
4 August, 2026571.8633 -0.13%
3 August, 2026572.6344 0.52%
31 July, 2026569.6988 -0.19%
30 July, 2026570.8114 -0.08%
29 July, 2026571.2438 1.19%
28 July, 2026564.4981 0.11%
27 July, 2026563.8608 1.39%
24 July, 2026556.1074 -0.22%
23 July, 2026557.3415 -0.39%
22 July, 2026559.5402 -1.62%
21 July, 2026568.7785 0.34%
20 July, 2026566.8426 1.05%
17 July, 2026560.9581 -1.13%
16 July, 2026567.3540 0.23%
15 July, 2026566.0639 0.26%
14 July, 2026564.5981 0.64%
13 July, 2026561.0211 -0.23%
10 July, 2026562.2939 0.34%
9 July, 2026560.3771 0.88%
8 July, 2026555.4759 -1.13%
7 July, 2026561.8106 -0.54%
6 July, 2026564.8352 0.11%
3 July, 2026564.2165 1.2%
2 July, 2026557.5002 0.44%
1 July, 2026555.0394

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 575.8043 as on 11 August, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.08% as on 11 August, 2026.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.57% as on 11 August, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 18.14% as on 11 August, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.3% as on 11 August, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.3% as on 11 August, 2026.